Activation of a specific part of the Dicer enzyme can change its shape in a way that affects its critical role in proper cell ...

Activation of a specific part of the Dicer enzyme can change its shape in a way that affects its critical role in proper cell ...

Pancreatic cancer remains one of the most difficult cancers to treat, in large part because tumors do not exist in isolation.

A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona provides one of the clearest roadmaps to date for understanding and treating liver cancer, one of the ...

New research has identified a protein that could serve as both a biomarker and therapeutic target to weaken stem-like cancer ...

Cep55, a centrosomal protein integral to cytokinesis, has emerged as a pivotal component in the progression of several cancers. Initially characterised for its role in mediating the final abscission ...

We need investment in precision medicine technologies to start programming cancer against itself, writes Cyriac Roeding.

ADAM proteins, a family of a disintegrin and metalloproteinases, are pivotal regulators of cell signalling and adhesion, primarily through their ability to mediate ectodomain shedding. This process ...

At AACR 2026, scientists showcased advances in radiotherapeutics, antibody-drug conjugates, T cell engagers, and ...

In recognition of Breast Cancer Awareness Month, join us for a live webinar to uncover the complexity of tumor biology and the surprising resilience of normal tissue. This event will feature two ...

To improve the treatment of patients with metastatic cancer, responsible for 67%-90% of all cancer-related deaths, there is an “urgent” need to abandon the classification of tumors by organ of origin, ...

Foundational preclinical data generated through research, hypothesis development, testing, and reiteration leads to the development of new approaches to treat the most recalcitrant solid tumors. As ...